Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients

It has been reported that certain patients with non-small-cell lung cancer (NSCLC) that harbor activating somatic mutations within the tyrosine kinase domain of the epidermal growth factor receptor (EGFR) gene may be effectively treated using targeted therapy. The use of EGFR inhibitors in patient t...

Descripción completa

Detalles Bibliográficos
Autores principales: PAPADOPOULOU, EIRINI, TSOULOS, NIKOLAOS, TSIRIGOTI, ANGELIKI, APESSOS, ANGELA, AGIANNITOPOULOS, KONSTANTINOS, METAXA-MARIATOU, VASILIKI, ZAROGOULIDIS, KONSTANTINOS, ZAROGOULIDIS, PAVLOS, KASARAKIS, DIMITRIOS, KAKOLYRIS, STYLIANOS, DAHABREH, JUBRAIL, VLASTOS, FOTIS, ZOUBLIOS, CHARALAMPOS, RAPTI, AGGELIKI, PAPAGEORGIOU, NIKI GEORGATOU, VELDEKIS, DIMITRIOS, GAGA, MINA, ARAVANTINOS, GERASIMOS, KARAVASILIS, VASILEIOS, KARAGIANNIDIS, NAPOLEON, NASIOULAS, GEORGE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579824/
https://www.ncbi.nlm.nih.gov/pubmed/26622815
http://dx.doi.org/10.3892/ol.2015.3600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579824/
https://www.ncbi.nlm.nih.gov/pubmed/26622815
http://dx.doi.org/10.3892/ol.2015.3600

Ejemplares similares